Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EG017 ointment for dry eye in postmenopausal women
NCT06133166Phase 2Unknown
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- Sep 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of EG017 ointment placebo in dry eye disease (DED), sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Status: unknown.
02
Drugs
EG017 ointment placebo
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT06133166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06133166.